骨科生物製剂市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球骨科生物製品市场规模为61亿美元，从2023年的64.3亿美元增长到2031年的98.7亿美元，在预测期内（2024-2031年）预计将以5.5%的复合年增长率增长。

由于几个关键因素，预计骨科生物製剂市场将在预测期内显着成长。运动伤害和道路事故发生频率的增加是预计推动市场扩张的两个重要因素。此外，脊椎疾病和病症发病率的增加预计将有助于市场成长。此外，患者对微创治疗的偏好增加也可能支持市场扩张，而与基于骨科生物製剂的治疗相关的高成本可能会成为市场限制。此外，老年人和肥胖人口的增加也是市场的顺风车，进一步加速了需求。骨生物製剂，也称为再生细胞疗法，由含有生长因子的产品组成，不仅可以缓解不适，还可以促进组织癒合并帮助恢復正常功能。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 供应链分析
• 市场生态系统
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 竞争程度

骨科生物製品市场：副产品

• 市场概况
• 关节内粘稠补充疗法产品
• 去矿物质骨基质
• 合成骨科生物製剂
• 骨形成蛋白
• 同种异体移植
• 血浆蛋白
• 骨髓抽吸浓缩液

骨科生物製品市场：依应用分类

• 市场概况
• 骨关节炎和退化性关节炎
• 脊椎融合手术
• 软组织损伤
• 骨折恢復
• 颚颜面和牙科应用

骨科生物製品市场：依最终使用者分类

• 市场概况
• 医院、整形外科诊所、门诊治疗中心
• 研究/学术机构
• 牙科诊所和设施

骨科生物製剂市场规模：依地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic PLC
• Stryker Corporation
• Globus Medical, Inc.
• Orthofix International NV
• RTI Surgical, Inc.
• Kuros Biosciences Ltd.
• Bioventus LLC
• Nuvasive, Inc.
• Seaspine Holdings Corporation
• Arthrex, Inc.
• Xtant Medical Holdings, Inc.
• Smith & Nephew plc
• Sanofi SA
• Integra LifeSciences Holdings Corporation
• Anika Therapeutics, Inc.
• Alphatec Spine, Inc.
• Orthocell Ltd.
• MiMedx Group, Inc.
• Orthofix Medical Inc.
• Bone Therapeutics SA

Global Orthobiologics Market size was valued at USD 6.1 billion in 2022 and is poised to grow from USD 6.43 billion in 2023 to USD 9.87 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

The orthobiologics market is expected to experience significant growth during the forecast period, driven by several key factors. The increasing frequency of sports injuries and traffic accidents are two prominent factors anticipated to fuel market expansion. Additionally, the rising incidence of spinal diseases and disorders is projected to contribute to the market's growth. Furthermore, the growing patient preference for minimally invasive procedures is likely to support market expansion, though this may be tempered by the high costs associated with orthobiologics-based treatments, which could act as a restraint. The market is also benefiting from the growing elderly and obese population, which further accelerates demand. Orthobiologics, also known as regenerative cellular therapies, comprise products containing growth factors that not only alleviate discomfort but also promote tissue healing and help restore normal function.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segmental Analysis

Global Orthobiologics Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate. Based on Application, the market is segmented into Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications. Based on End User, the market is segmented into Hospitals, Orthopedic Clinics, & Ambulatory Care Centers, Research & Academic Institutes, Dental Clinics and Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Orthobiologics Market

Viscosupplements are in high demand and are expected to significantly contribute to the growth of the orthobiologics market. Knee osteoarthritis, a common issue among the elderly, is extensively treated with viscosupplements, which are hyaluronic acid injections administered directly into the joints. The expansion of the viscosupplements segment is driven by factors such as high product costs, the entry of new manufacturers, and recent marketing approvals. Additionally, the segment is benefiting from improved reimbursement policies, further enhancing its growth prospects. Given these factors, the increasing demand for viscosupplements is anticipated to drive the expansion of the global orthobiologics market during the forecast period.

Restraints in the Global Orthobiologics Market

The growing patient preference for minimally invasive procedures is expected to present challenges to the expansion of the orthobiologics market. Additionally, the market may face further difficulties due to the adverse effects associated with BMP-based therapy. Another significant constraint is the surging prices of orthobiologics-based treatments, which may hinder market growth throughout the forecast period. The complex synthesis processes, stringent manufacturing regulations, and high production costs further limit market expansion. Moreover, the high costs associated with orthobiologics products and treatments, coupled with inadequate reimbursement policies, are major obstacles impeding the growth of the global orthobiologics market.

Market Trends of the Global Orthobiologics Market

The global orthobiologics market is expected to grow significantly, driven by the high prevalence of sports-related injuries. For example, a study titled "Results on Sports-Related Injuries in Children from NHS Emergency Care Dataset Oxfordshire Pilot: An Ecological Study," published in November 2018, revealed that 47.4 percent of emergency department visits related to sports injuries involved children aged 0 to 19, and approximately 23.5 percent of all age groups' admissions were due to sports injuries. However, the cost of orthobiologics is variable in the global market. According to a University of Alabama at Birmingham study, as reported in an article published in Sports Health in October 2019, the cost of orthobiologics therapy can range from a few hundred dollars to as much as $12,000. This price fluctuation adds a layer of complexity to the market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Ecosystem of the Market
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Orthobiologics Market by Product

• Market Overview
• Viscosupplementation Products
• Demineralized Bone Matrices
• Synthetic Orthobiologics
• Bone Morphogenic Protein
• Allografts
• Plasma-Rich Protein
• Bone Marrow Aspirate Concentrate

Orthobiologics Market by Application

• Market Overview
• Osteoarthritis and Degenerative Arthritis
• Spinal Fusion
• Soft-Tissue Injuries
• Fracture Recovery
• Maxillofacial and Dental Applications

Orthobiologics Market by End User

• Market Overview
• Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
• Research & Academic Institutes
• Dental Clinics and Facilities

Orthobiologics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix International N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Surgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seaspine Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alphatec Spine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthocell Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiMedx Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bone Therapeutics SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments